GABAA receptor subunit beta1 is involved in the formation of protease-resistant prion protein in prion-infected neuroblastoma cells.

Tomohiro Kimura, Kensuke Ishikawa, Yuji Sakasegawa, Kenta Teruya, Tetsutaro Sata, Hermann Schätzl, Katsumi Doh-ura

文献索引：FEBS Lett. 584(6) , 1193-8, (2010)

全文：HTML全文

摘要

Gamma-aminobutyric acid type A (GABAA) receptor beta1 (gabrb1), a subunit of GABAA receptors involved in inhibitory effects on neurotransmission, was found to associate with the formation of protease-resistant prion protein in prion-infected neuroblastoma cells. Silencing of gabrb1 gene expression significantly decreased the abnormal prion protein level but paradoxically increased the normal prion protein level. Treatment with a gabrb1-specific inhibitor, salicylidene salicylhydrazide, dose-dependently decreased the abnormal prion protein level, but silencing of other GABAA receptor subunits' gene expression and treatments with the receptor antagonists and agonists did not. Therefore, gabrb1 involvement in abnormal prion protein formation is independent of GABAA receptors.Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.